| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Giuseppe d'Orsi, Vincenzo Demaio, L M Specchi. Pathological gambling plus hypersexuality in restless legs syndrome: a new case. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 32. issue 4. 2011-11-15. PMID:21567182. |
emerging clinical data indicate that dopaminergic agonists used to treat restless legs syndrome may be associated with dopamine dysregulation syndrome, particularly pathological gambling. |
2011-11-15 |
2023-08-12 |
Not clear |
| Giuseppe d'Orsi, Vincenzo Demaio, L M Specchi. Pathological gambling plus hypersexuality in restless legs syndrome: a new case. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 32. issue 4. 2011-11-15. PMID:21567182. |
our new case confirms that restless legs syndrome patients should be cautioned about potential dopamine dysregulation syndrome coinciding with dopaminergic agonists, as it can be reversed by drug withdrawal. |
2011-11-15 |
2023-08-12 |
Not clear |
| Matthew Graham Cripp. Acupuncture for restless legs syndrome in patients previously treated with dopaminergic drugs. Acupuncture in medicine : journal of the British Medical Acupuncture Society. vol 29. issue 3. 2011-11-08. PMID:21697212. |
acupuncture for restless legs syndrome in patients previously treated with dopaminergic drugs. |
2011-11-08 |
2023-08-12 |
Not clear |
| Ulrike H Mitchell, J William Myrer, A Wayne Johnson, Sterling C Hilto. Restless legs syndrome and near-infrared light: An alternative treatment option. Physiotherapy theory and practice. vol 27. issue 5. 2011-10-07. PMID:20977377. |
there are few treatment options in managing restless legs syndrome (rls); the most frequently used are dopaminergic drugs and movement. |
2011-10-07 |
2023-08-12 |
human |
| Tiago Machado Guerreiro, Danilo Ryuko Cândido Nishikawa, Lis Campos Ferreira, Hyder Aragão de Melo, Roberto César Pereira do Prad. Restless legs syndrome in Parkinson's disease: clinical characteristics and biochemical correlations. Arquivos de neuro-psiquiatria. vol 68. issue 6. 2011-09-28. PMID:21243243. |
restless legs syndrome (rls) is a neurological disorder that responds to dopaminergic drugs, indicating a common pathophysiology with parkinson's disease (pd). |
2011-09-28 |
2023-08-12 |
Not clear |
| Sandra J England, Daniel L Picchietti, Barbara Vera Couvadelli, Barbara C Fisher, Fouzia Siddiqui, Mary L Wagner, Wayne A Hening, Daniel Lewin, Glenna Winnie, Barry Cohen, Arthur S Walter. L-Dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit-Hyperactivity Disorder in a double-blind trial in children. Sleep medicine. vol 12. issue 5. 2011-09-01. PMID:21463967. |
in a previous open-label study, dopaminergic agents improved restless legs syndrome (rls) and periodic limb movements in sleep (plms), as well as attention-deficit-hyperactivity disorder (adhd) in children with both disorders. |
2011-09-01 |
2023-08-12 |
Not clear |
| Diego García-Borreguero, Anne-Marie William. Dopaminergic augmentation of restless legs syndrome: the scope of the problem. Sleep medicine. vol 12. issue 5. 2011-09-01. PMID:21493133. |
dopaminergic augmentation of restless legs syndrome: the scope of the problem. |
2011-09-01 |
2023-08-12 |
Not clear |
| Anne-Marie Williams, Diego Garcia-Borreguer. Management of restless legs syndrome augmentation. Current treatment options in neurology. vol 11. issue 5. 2011-07-14. PMID:19744398. |
augmentation is the main complication of long-term dopaminergic treatment of restless legs syndrome (rls). |
2011-07-14 |
2023-08-12 |
Not clear |
| Ulrike H Mitchel. Use of near-infrared light to reduce symptoms associated with restless legs syndrome in a woman: a case report. Journal of medical case reports. vol 4. 2011-07-14. PMID:20731851. |
contemporary treatment for restless legs syndrome consists mostly of dopaminergic drugs that leave some patients feeling nauseated and dizzy. |
2011-07-14 |
2023-08-12 |
Not clear |
| Clete A Kushid. Ropinirole for the treatment of restless legs syndrome. Neuropsychiatric disease and treatment. vol 2. issue 4. 2011-05-17. PMID:19412490. |
dopaminergic agents, anticonvulsants, benzodiazepines, opiates, and iron supplementation comprise the classes of medications commonly used to treat restless legs syndrome (rls), which is a disorder that is estimated to affect about 1 in 10 individuals worldwide and impacts an affected patient's sleep, mood, daytime function, and quality of life. |
2011-05-17 |
2023-08-12 |
Not clear |
| Benjamin C Cheah, Matthew C Kierna. Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis. IDrugs : the investigational drugs journal. vol 13. issue 12. 2011-05-02. PMID:21154151. |
pramipexole, exclusively the s(-) enantiomer, is a non-ergot dopaminergic autoreceptor agonist that is currently marketed for use in the treatment of parkinson's disease and restless legs syndrome. |
2011-05-02 |
2023-08-12 |
Not clear |
| Jose Carlos Pereira, Marcia Pradella-Hallinan, Hugo de Lins Pesso. Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis. Clinics (Sao Paulo, Brazil). vol 65. issue 5. 2011-04-07. PMID:20535374. |
imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis. |
2011-04-07 |
2023-08-12 |
Not clear |
| Jose Carlos Pereira, Marcia Pradella-Hallinan, Hugo de Lins Pesso. Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis. Clinics (Sao Paulo, Brazil). vol 65. issue 5. 2011-04-07. PMID:20535374. |
data collected from medical literature indicate that dopaminergic agonists alleviate restless legs syndrome symptoms while dopaminergic agonists antagonists aggravate them. |
2011-04-07 |
2023-08-12 |
Not clear |
| Jose Carlos Pereira, Marcia Pradella-Hallinan, Hugo de Lins Pesso. Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis. Clinics (Sao Paulo, Brazil). vol 65. issue 5. 2011-04-07. PMID:20535374. |
low iron levels can cause secondary restless legs syndrome or aggravate symptoms of primary disease as well as diminish enzymatic activities that are involved in dopaminergic agonists production and the degradation of thyroid hormones. |
2011-04-07 |
2023-08-12 |
Not clear |
| Jose Carlos Pereira, Marcia Pradella-Hallinan, Hugo de Lins Pesso. Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis. Clinics (Sao Paulo, Brazil). vol 65. issue 5. 2011-04-07. PMID:20535374. |
to discuss the theory that thyroid hormones, when not counterbalanced by dopaminergic agonists, may precipitate the signs and symptoms underpinning restless legs syndrome. |
2011-04-07 |
2023-08-12 |
Not clear |
| Jose Carlos Pereira, Marcia Pradella-Hallinan, Hugo de Lins Pesso. Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis. Clinics (Sao Paulo, Brazil). vol 65. issue 5. 2011-04-07. PMID:20535374. |
the main cause of restless legs syndrome might be an imbalance between the dopaminergic agonists system and thyroid hormones. |
2011-04-07 |
2023-08-12 |
Not clear |
| Ulf Kallweit, Ramin Khatami, Fabio Pizza, Johannes Mathis, Claudio L Bassett. Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness. Clinical neuropharmacology. vol 33. issue 6. 2011-03-29. PMID:21060282. |
dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness. |
2011-03-29 |
2023-08-12 |
Not clear |
| Sophie Bayard, Huan Yu, Muriel Croisier Langenier, Bertrand Carlander, Yves Dauvillier. Decision making in restless legs syndrome. Movement disorders : official journal of the Movement Disorder Society. vol 25. issue 15. 2011-02-25. PMID:20669306. |
although the pathophysiology of restless legs syndrome (rls) is not yet fully understood, the genetic factors, iron status, and dopaminergic system are thought to play a role. |
2011-02-25 |
2023-08-12 |
human |
| Rachel E Salas, Charlene E Gamaldo, Richard P Alle. Update in restless legs syndrome. Current opinion in neurology. vol 23. issue 4. 2011-02-15. PMID:20581683. |
although restless legs syndrome (rls) is a disorder recognized in the medical literature since the 17th century, there have only recently been significant clinical and scientific advances in diagnosis, epidemiology and understanding the disorder, mainly due to the advent of dopaminergic treatment. |
2011-02-15 |
2023-08-12 |
Not clear |
| Pascal Dowling, Florian Klinker, Christine Stadelmann, Kenan Hasan, Walter Paulus, David Liebetan. Dopamine D3 receptor specifically modulates motor and sensory symptoms in iron-deficient mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 31. issue 1. 2011-02-04. PMID:21209191. |
restless legs syndrome (rls) is a common neurological disorder whose exact pathophysiological mechanism remains unclear despite the successful use of dopaminergic treatment and recent discovery of predisposing genetic factors. |
2011-02-04 |
2023-08-12 |
mouse |